News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,289 Results
Type
Article (5121)
Company Profile (24)
Press Release (227144)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82336)
Career Advice (464)
Deals (15064)
Drug Delivery (8)
Drug Development (19077)
Employer Resources (30)
FDA (3687)
Job Trends (3917)
News (120306)
Policy (7549)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14843)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (40)
Approvals (3787)
Artificial intelligence (81)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2871)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (889)
Cardiovascular disease (61)
Career advice (396)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16687)
Collaboration (353)
Compensation (373)
Complete response letters (8)
COVID-19 (313)
CRISPR (13)
C-suite (340)
Cystic fibrosis (28)
Data (1329)
Denatured (1)
Depression (21)
Diabetes (79)
Diagnostics (2116)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42754)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39167)
Executive appointments (425)
FDA (4427)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (341)
Gene editing (24)
Generative AI (5)
Gene therapy (103)
GLP-1 (144)
Government (430)
Guidances (197)
Healthcare (5058)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (339)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7883)
IRA (3)
Job creations (1124)
Job search strategy (362)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2360)
Liver cancer (21)
Longevity (2)
Lung cancer (94)
Lymphoma (71)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3919)
Medtech (3929)
Mergers & acquisitions (7586)
Metabolic disorders (217)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (540)
NextGen: Class of 2026 (1681)
Non-profit (745)
Now hiring (5)
Obesity (86)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (53)
Patient recruitment (98)
Peanut (6)
People (25256)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4995)
Phase 2 (7227)
Phase 3 (5791)
Pipeline (1977)
Policy (17)
Postmarket research (625)
Preclinical (1948)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (180)
Real estate (1890)
Recruiting (8)
Regulatory (5549)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (55)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (6)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (17)
Last 7 days (150)
Last 30 days (544)
Last 365 days (8912)
2026 (815)
2025 (9041)
2024 (11037)
2023 (13218)
2022 (18684)
2021 (19698)
2020 (18268)
2019 (13234)
2018 (10251)
2017 (10016)
2016 (9170)
2015 (12124)
2014 (9590)
2013 (7709)
2012 (8329)
2011 (8798)
2010 (8642)
Location
Africa (187)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11790)
Australia (1692)
California (3542)
Canada (1139)
China (168)
Colorado (144)
Connecticut (163)
Delaware (70)
Europe (25503)
Florida (542)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (106)
Iowa (9)
Japan (165)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2811)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1027)
New Mexico (5)
New York (817)
North Carolina (480)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (602)
Puerto Rico (1)
Rhode Island (19)
South America (280)
South Carolina (17)
Southern California (1305)
Tennessee (61)
Texas (484)
United States (12364)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,289 Results for "amerisourcebergen corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement
Sapphiros is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.
November 22, 2023
·
2 min read
Pharm Country
AmerisourceBergen Specialty Group Provides Substitute Notice of Data Incident to Affected Individuals
AmerisourceBergen Specialty Group, LLC is issuing notice to individuals who may have been impacted by a data security incident.
May 24, 2024
·
2 min read
BioMidwest
Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
Walgreens Boots Alliance, Inc. announced that it has sold shares of AmerisourceBergen Corporation common stock pursuant to prepaid variable share forward transactions executed through a registered public offering for current proceeds of approximately $1.6 billion.
August 3, 2023
·
5 min read
Deals
TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
TPG and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.
June 9, 2023
·
2 min read
Biotech Bay
Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
Tivic Health® Systems, Inc. announced that the Company has entered into a non-exclusive agreement with AmerisourceBergen, soon to be Cencora, to make Tivic’s products available on AmerisourceBergen’s third-party marketplace.
August 28, 2023
·
3 min read
Business
AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors
AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023.
August 15, 2023
·
2 min read
Deals
Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
Walgreens Boots Alliance, Inc. announced that it has sold shares of AmerisourceBergen Corporation common stock pursuant to variable prepaid forward transactions executed in reliance on Rule 144 of the Securities Act of 1933, as amended, for current proceeds of approximately $644 million.
May 11, 2023
·
4 min read
Business
AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
AmerisourceBergen Corporation reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent year-over-year to $66.9 billion.
August 2, 2023
·
49 min read
Business
Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange.
October 2, 2023
·
2 min read
Deals
AmerisourceBergen Completes Acquisition of PharmaLex
AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of its acquisition of PharmaLex Holding GmbH.
January 3, 2023
·
1 min read
1 of 23,229
Next
